Abstract
Since its first application more than 40 years ago, extracorporeal membrane oxygenation (ECMO) has emerged, with the improvement of biocompatible technologies, as a salvage option for patients in severe cardiopulmonary failure refractory to conventional management. ECMO has shown potential to improve outcomes in lung transplant recipients who develop severe primary graft dysfunction (PGD) refractory to standard supportive care. PGD is the syndrome of acute lung injury within 72 h from transplantation and it represents one of the most common causes of morbidity and mortality in lung transplant recipients. PGD is characterized by diffuse pulmonary infiltrates on radiological imaging and hypoxemia without other identifiable causes. Severe PGD (grade 3) is associated with high early mortality and requires complex management with a multidisciplinary team approach. Peripheral veno-venous (VV) ECMO is the most common cannulation strategy. Patients presenting with pulmonary hypertension, right ventricular failure and hemodynamic instability will require full circulatory support with veno-arterial (VA) ECMO. Cannulation is typically performed percutaneously under ultrasound guidance. After a few days of ECMO support, when cardiopulmonary function is recovered, the patient can be managed to be weaned off the ECMO circuit. Earlier initiation of ECMO has been associated with better outcomes and in recent years ECMO has been used “prophylactically” in patients at high-risk of PGD development. Efficient ECMO implementation and appropriate choice of the cannulation strategy are crucial to avoid unrecoverable clinical deterioration and life-threatening complications and to achieve the best possible outcome in this complex patient population.
This is a preview of subscription content, log in via an institution to check access.
References
Abrams D, Combes A, Brodie D (2014) Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 63:2769–2778. https://doi.org/10.1016/j.jacc.2014.03.046
Abrams D, Brodie D, Arcasoy SM (2017) Extracorporeal life support in lung transplantation. Clin Chest Med 38:655–666. https://doi.org/10.1016/j.ccm.2017.07.006
Aigner C, Slama A, Barta M et al (2018) Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: a prospective, randomized pilot study. J Heart Lung Transplant 37:225–231. https://doi.org/10.1016/j.healun.2017.09.021
Aissaoui N, El-Banayosy A, Combes A (2015) How to wean a patient from veno-arterial extracorporeal membrane oxygenation. Intensive Care Med 41:902–905. https://doi.org/10.1007/s00134-015-3663-y
Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D et al (2009) Extracorporeal membrane oxygenation for 2009 influenza a(H1N1) acute respiratory distress syndrome. JAMA 302:1888–1895. https://doi.org/10.1001/jama.2009.1535
Bartlett RH (2017) Esperanza: the first neonatal ECMO patient. ASAIO J 63:832–843. https://doi.org/10.1097/MAT.0000000000000697
Bermudez CA, Daneshmand MA (2020) 6 – The role of extracorporeal membrane oxygenation in cardiac support. In: Kirklin JK, Rogers JG (eds) Mechanical circulatory support: a companion to Braunwald’s heart disease, 2nd edn. Elsevier, Philadelphia, pp 53–70
Bermudez CA, Adusumilli PS, McCurry KR et al (2009) Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival. Ann Thorac Surg 87:854–860. https://doi.org/10.1016/j.athoracsur.2008.11.036
Bermudez CA, Rocha RV, Sappington PL et al (2010) Initial experience with single cannulation for venovenous extracorporeal oxygenation in adults. Ann Thorac Surg 90:991–995. https://doi.org/10.1016/j.athoracsur.2010.06.017
Broman LM, Malfertheiner MV, Montisci A, Pappalardo F (2018) Weaning from veno-venous extracorporeal membrane oxygenation: how I do it. J Thorac Dis 10:S692–S697. https://doi.org/10.21037/jtd.2017.09.95
Carter KT, Kutcher ME, Shake JG et al (2019) Heparin-sparing anticoagulation strategies are viable options for patients on Veno-venous ECMO. J Surg Res 243:399–409. https://doi.org/10.1016/j.jss.2019.05.050
Castleberry AW, Hartwig MG, Whitson BA (2013) Extracorporeal membrane oxygenation post lung transplantation. Curr Opin Organ Transplant 18:524–530. https://doi.org/10.1097/MOT.0b013e328365197e
Christie JD, Bavaria JE, Palevsky HI et al (1998) Primary graft failure following lung transplantation. Chest 114:51–60
Christie JD, Carby M, Bag R et al (2005a) Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24:6
Christie JD, Van Raemdonck D, de Perrot M et al (2005b) Report of the ISHLT working group on primary lung graft dysfunction part I: introduction and methods. J Heart Lung Transplant 24:1451–1453. https://doi.org/10.1016/j.healun.2005.03.004
Christie JD, Edwards LB, Kucheryavaya AY et al (2012) The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report – 2012. J Heart Lung Transplant 31:1073–1086. https://doi.org/10.1016/j.healun.2012.08.004
Cypel M, Liu M, Rubacha M et al (2009) Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 1:4ra9. https://doi.org/10.1126/scitranslmed.3000266
de Perrot M, Liu M, Waddell TK, Keshavjee S (2003) Ischemia–reperfusion–induced lung injury. Am J Respir Crit Care Med 167:490–511. https://doi.org/10.1164/rccm.200207-670SO
den Hengst WA, Gielis JF, Lin JY et al (2010) Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Phys Heart Circ Phys 299:H1283–H1299. https://doi.org/10.1152/ajpheart.00251.2010
Diamond JM, Lee JC, Kawut SM et al (2013) Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 187:527–534. https://doi.org/10.1164/rccm.201210-1865OC
Diamond JM, Arcasoy S, Kennedy CC et al (2017) Report of the International Society for Heart and Lung Transplantation working group on primary lung graft dysfunction, part II: epidemiology, risk factors, and outcomes – a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 36:1104–1113. https://doi.org/10.1016/j.healun.2017.07.020
ELSO (2019) Extra Corporal Life Support Registry Report. https://www.elso.org/Portals/0/Files/Reports/2019/International%20Summary%20July%202019%20page%201.pdf. Accessed 22 Nov 2019
Fischer S, Bohn D, Rycus P et al (2007) Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the extracorporeal life support organization (ELSO) registry. J Heart Lung Transplant 26:472–477. https://doi.org/10.1016/j.healun.2007.01.031
Garcia JP, Kon ZN, Evans C et al (2011) Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls. J Thorac Cardiovasc Surg 142:755–761. https://doi.org/10.1016/j.jtcvs.2011.07.029
Gelman AE, Fisher AJ, Huang HJ et al (2017) Report of the ISHLT working group on primary lung graft dysfunction part III: mechanisms: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 36:1114–1120. https://doi.org/10.1016/j.healun.2017.07.014
Hartwig MG, Appel JZ, Cantu E et al (2005) Improved results treating lung allograft failure with venovenous extracorporeal membrane oxygenation. Ann Thorac Surg 80:1872–1879; discussion 1879–1880. https://doi.org/10.1016/j.athoracsur.2005.04.063
Hartwig MG, Walczak R, Lin SS, Davis RD (2012) Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. Ann Thorac Surg 93:366–371. https://doi.org/10.1016/j.athoracsur.2011.05.017
Haydock DA et al (1992) Management of dysfunction in the transplanted lung: experience with 7 clinical cases. Ann Thorac Surg 53(4):635–641. Accessed 20 Nov 2019
Hayes K, Hodgson CL, Pellegrino VA et al (2018) Physical function in subjects requiring extracorporeal membrane oxygenation before or after lung transplantation. Respir Care 63:194–202. https://doi.org/10.4187/respcare.05334
Hill JD, O’Brien TG, Murray JJ et al (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 286:629–634. https://doi.org/10.1056/NEJM197203232861204
Hoetzenecker K, Benazzo A, Stork T et al (2020) Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study. J Thorac Cardiovasc Surg 160:320–327.e1. https://doi.org/10.1016/j.jtcvs.2019.10.155
Kahn SU et al (1999) Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 116(1):187–194. Accessed 20 Nov 2019
Kawut SM, Lederer DJ, Keshavjee S et al (2008) Outcomes after lung retransplantation in the modern era. Am J Respir Crit Care Med 177:114–120. https://doi.org/10.1164/rccm.200707-1132OC
Kreisel D, Krupnick AS, Puri V et al (2011) Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg 141:215–222. https://doi.org/10.1016/j.jtcvs.2010.09.009
La Francesca S, Ting AE, Sakamoto J et al (2014) Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study. Transp Res 3:19. https://doi.org/10.1186/2047-1440-3-19
Lee JC, Christie JD (2011) Primary graft dysfunction. Clin Chest Med 32:279–293. https://doi.org/10.1016/j.ccm.2011.02.007
Lo Coco V, Lorusso R, Raffa GM et al (2018) Clinical complications during veno-arterial extracorporeal membrane oxigenation in post-cardiotomy and non post-cardiotomy shock: still the Achille’s heel. J Thorac Dis 10:6993–7004. https://doi.org/10.21037/jtd.2018.11.103
Mulvihill MS, Yerokun BA, Davis RP et al (2018) Extracorporeal membrane oxygenation following lung transplantation: indications and survival. J Heart Lung Transplant 37:259–267. https://doi.org/10.1016/j.healun.2017.06.014
Ortuno S, Delmas C, Diehl J-L et al (2019) Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use? Ann Cardiothorac Surg 8:E1–E8. https://doi.org/10.21037/acs.2018.08.05
Pavlushkov E, Berman M, Valchanov K (2017) Cannulation techniques for extracorporeal life support. Ann Transl Med 5:4–4. https://doi.org/10.21037/atm.2016.11.47
Peek GJ, Clemens F, Elbourne D et al (2006) CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res 6:163. https://doi.org/10.1186/1472-6963-6-163
Porteous MK, Lee JC (2017) Primary graft dysfunction after lung transplantation. Clin Chest Med 38:641–654. https://doi.org/10.1016/j.ccm.2017.07.005
Prekker ME, Nath DS, Walker AR et al (2006) Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 25:371–378. https://doi.org/10.1016/j.healun.2005.11.436
Sertic F, Crespo MM, Milas B, Bermudez C (2019) Early diagnosis and management of pulmonary vein thrombosis following lung transplant. J Thorac Cardiovasc Surg 157:e419–e421. https://doi.org/10.1016/j.jtcvs.2019.02.002
Siegelman SS, Sinha SBP, Veith FJ (1973) Pulmonary reimplantation response. Ann Surg 177:30–36. https://doi.org/10.1097/00000658-197301000-00006
Sleiman C, Mal H, Fournier M et al (1995) Pulmonary reimplantation response in single-lung transplantation. Eur Respir J 8:5–9. https://doi.org/10.1183/09031936.95.08010005
Snell GI, Yusen RD, Weill D et al (2017) Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading – a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 36:1097–1103. https://doi.org/10.1016/j.healun.2017.07.021
Sommer W, Tudorache I, Kühn C et al (2014) C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. Transplantation 97:1185–1191. https://doi.org/10.1097/TP.0000000000000034
Strüber M, Fischer S, Niedermeyer J et al (2007) Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 133:1620–1625. https://doi.org/10.1016/j.jtcvs.2006.12.057
Vaquer S, de Haro C, Peruga P et al (2017) Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome. Ann Intensive Care 7:51. https://doi.org/10.1186/s13613-017-0275-4
Veit T, Leuschner G, Sisic A et al (2019) Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation. Am J Transplant 19:2358–2365. https://doi.org/10.1111/ajt.15378
Whitson BA, Nath DS, Johnson AC et al (2006) Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 131:73–80. https://doi.org/10.1016/j.jtcvs.2005.08.039
Zangrillo A, Biondi-Zoccai G, Landoni G et al (2013) Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 17:R30. https://doi.org/10.1186/cc12512
Zapol WM, Snider MT, Hill JD et al (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196. https://doi.org/10.1001/jama.242.20.2193
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 UPMC Italy S.R.L.
About this entry
Cite this entry
Sertic, F., Bermudez, C. (2023). Use of Extracorporeal Membrane Oxygenation (ECMO) After Surgery: Management of Primary Graft Dysfunction (PGD). In: Bertani, A., Vitulo, P., Grossi, P.A. (eds) Contemporary Lung Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-20788-9_37-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20788-9_37-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20788-9
Online ISBN: 978-3-319-20788-9
eBook Packages: Springer Reference MedicineReference Module Medicine